Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
HungaryStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
HungaryStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease
HungaryStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
HungaryStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
HungaryStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
HungaryStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
HungaryStudy on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy
HungaryStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
HungaryStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
